| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 11.06. | Report from the Annual General Meeting 2025 of IRLAB Therapeutics AB | GOTHENBURG, SWEDEN / ACCESS Newswire / June 11, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) - Today, on Wednesday June 11, 2025, IRLAB Therapeutics AB held its Annual General Meeting.The following... ► Artikel lesen | |
| 04.06. | IRLAB Therapeutics: IRLAB Participates in Aktiespararna's Event - Aktiedagarna | GOTHENBURG, SE / ACCESS Newswire / June 4, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) - Gothenburg, Sweden, June 4, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering... ► Artikel lesen | |
| 28.05. | IRLAB Therapeutics: IRLAB Reports Positive Results from the Second Part of a Phase I Study with IRL757 | GOTHENBURG, SE / ACCESS Newswire / May 28, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) - Gothenburg, Sweden, May 28, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company that discovers... ► Artikel lesen | |
| 15.05. | IRLAB Therapeutics: IRLAB to Present at BioStock Global Forum 2025 | GOTHENBURG, SE / ACCESS Newswire / May 15, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) - Gothenburg, Sweden, May 15, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company that discovers... ► Artikel lesen | |
| 13.05. | IRLAB Therapeutics: IRLAB is Granted a Patent Expanding the Patent Protection for the Drug Candidate Mesdopetam in the US | GOTHENBURG, SE / ACCESS Newswire / May 13, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) - Gothenburg, Sweden, May 13, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering... ► Artikel lesen |
